Alpha Profiles · Company Profile

INTEGRA LIFESCIENCES HOLDINGS CORP

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/integra-lifesciences-holdings-corp

Entity: Public listing published
Primary listing: NASDAQ: IART
Verification: Partially verified
Last reviewed: 2026-09-13T04:46:01.80734+00:00

Overview

Alpha's canonical identity and public leadership record for INTEGRA LIFESCIENCES HOLDINGS CORP.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

11 public records

Chantal Veillon

Executive Vice President and Chief Human Resources Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Eric I. Schwartz

Executive Vice President, Chief Legal Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: IART executive roster sourceMay 3, 2026

Harvinder Singh

Executive Vice President and President, International

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Jan De Witte

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: IART executive roster sourceMay 3, 2026

Jeffrey Mosebrook

Senior Vice President, Finance and Principal Accounting Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Lea Knight

Executive Vice President and Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Lester B. Knight

Executive Vice President and Chief Financial Officer

State: confirmed
Effective: From Apr 6, 2026
Confidence: 94%
Evidence: IART DEF 14A executive officersApr 6, 2026

Michael Hutchinson

Executive Vice President, Chief Legal Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Michael McBreen

Executive Vice President, President, Codman Specialty Surgical

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Mojdeh Poul

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Robert T. Davis, Jr.

Executive Vice President, President, Tissue Technologies

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000917520-26-000015Apr 6, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.